In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers.
Morning Overview on MSN
Billionaires chase immortality as Harvard-backed startup wins FDA nod for 1st partial de-aging trial
The race to slow, halt, or even reverse aging has moved from science fiction into the regulatory record. A Harvard-linked ...
Life Biosciences will test its gene therapy designed to partially reset a cell’s age and potentially reverse vision loss in ...
AUSTIN, Texas, March 07, 2025 (GLOBE NEWSWIRE) -- Renowned neuroscientist, psychiatrist, and author, Jeffrey A. Lieberman, M.D., and world-leading longevity scientist ...
Harvard geneticist David Sinclair’s seductive notion that aging is a treatable disease has helped companies he founded to raise more than $1 billion. The investors have almost nothing to show for it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results